Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Biology and Environment (32)
- Advanced Manufacturing (2)
- Biology and Soft Matter (1)
- Clean Energy (53)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Materials (65)
- Materials for Computing (10)
- National Security (8)
- Neutron Science (103)
- Nuclear Science and Technology (6)
- Supercomputing (23)
- Transportation Systems (1)
News Topics
- (-) Chemical Sciences (11)
- (-) Decarbonization (19)
- (-) Neutron Science (4)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Artificial Intelligence (9)
- Big Data (10)
- Bioenergy (45)
- Biology (73)
- Biomedical (16)
- Biotechnology (13)
- Buildings (2)
- Clean Water (11)
- Climate Change (41)
- Composites (5)
- Computer Science (19)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Energy Storage (7)
- Environment (90)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (9)
- Materials (12)
- Materials Science (6)
- Mathematics (4)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (15)
- Summit (10)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.